Recent News

It's the amount you lose, not the diet you're on, that matters in reversing cancer-obesity link

It's the amount you lose, not the diet you're on, that matters in reversing cancer-obesity link

Researchers with UNC Lineberger examined whether weight loss via four different diets was linked to reduced tumor growth in laboratory models of breast cancer. While tumor size did not differ between obese mice and obese mice that returned to a normal weight on a low-fat diet, they did find that obese mice that lost significant amounts of weight on three calorie-restricted diets had smaller tumors.

It's the amount you lose, not the diet you're on, that matters in reversing cancer-obesity link - Read More…

Genetic differences for kidney cancer may contribute to survival disparity in African-Americans

Genetic differences for kidney cancer may contribute to survival disparity in African-Americans

A UNC Lineberger-led study has identified genetic differences in tumors of African-Americans with the most common type of kidney cancer compared with whites. The researchers, led by senior author Dr. William "Billy" Kim, say the findings could help explain lower survival rates for African-Americans with clear cell renal cell carcinoma.

Genetic differences for kidney cancer may contribute to survival disparity in African-Americans - Read More…

New compound is effective against drug-resistant leukemia, preclinical study finds

New compound is effective against drug-resistant leukemia, preclinical study finds

Researchers at UNC Lineberger and at other institutions developed a new potential treatment for acute myeloid leukemia. In the journal JCI Insight, they report that the compound MRX-2843 more than doubled the median days of survival in laboratory models with a drug-resistant form of the disease.

New compound is effective against drug-resistant leukemia, preclinical study finds - Read More…

UNC experts discover colorectal cancer biomarker, potential personalized treatment

UNC experts discover colorectal cancer biomarker, potential personalized treatment

In the journal Cell Reports, UNC Lineberger researchers reported they found markedly low levels of the protein NLRX1 in multiple laboratory models of colorectal cancer, and in samples of human tissue. Studies have shown that the protein is known to be involved in regulating immune system signals in order to prevent hyperactive inflammatory responses by the immune system, but UNC Lineberger researchers believe their finding also points to a role for the protein in preventing colorectal cancer growth. Based on their findings, they believe they’ve identified a potential treatment for colorectal cancer with low NLRX1.

UNC experts discover colorectal cancer biomarker, potential personalized treatment - Read More…